Effectiveness and safety of bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with ST-elevation myocardial infarction

被引：0
|
作者：
Filipa Melao, F. [1 ]
Ribeiro, V. [1 ]
Rodrigues, R. [1 ]
Lopes, R. [1 ]
Pereira, M. [2 ]
Silva, J. C. [1 ]
Maciel, M. J. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Oporto, Portugal
[2] Univ Porto, Sch Med, Dept Hyg & Epidemiol, P-4100 Oporto, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1582
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [1] Glycoprotein IIb/IIIa receptor inhibitors versus bivalirudin in patients with ST-segment elevation myocardial infarction
    Angeras, Oskar
    Ioanes, Dan
    Ramunddal, Truls
    Omerovic, Elmir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B82 - B82
  • [2] Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction
    Schwenkglenks, Matthias
    Toward, Toby J.
    Plent, Stephanie
    Szucs, Thomas D.
    Blackman, Daniel J.
    Baumbach, Andreas
    HEART, 2012, 98 (07) : 544 - 551
  • [3] Clinical Benefits of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Elevation Myocardial Infarction
    Sim, Doo Sun
    Ahn, Youngkeun
    Jeong, Myung Ho
    Kim, Young Jo
    Chae, Shung Chull
    Hong, Taek Jong
    Seong, In Whan
    Chae, Jei Keon
    Kim, Chong Jin
    Cho, Myeong Chan
    Seung, Ki Bae
    Park, Seung Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 36B - 36B
  • [4] Bivalirudin versus UFH with or without GP IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary PCI
    Venetsanos, D.
    Lawesson, S. Sederholm
    James, S.
    Erlinge, D.
    Koul, S.
    Swahn, E.
    Alfredsson, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1021 - 1021
  • [5] Bivalirudin for patients with ST-elevation myocardial infarction
    Dwivedi, Girish
    Steed, Richard
    Chong, Aun Yeong
    LANCET, 2011, 378 (9807): : 1915 - 1915
  • [6] Safety and efficacy of rescue angioplasty for ST-elevation myocardial infarction with high utilization rates of glycoprotein IIb/IIIa inhibitors
    Shugman, Ibrahim M.
    Hsieh, Victar
    Cheng, Samuel
    Parikh, Devang
    Tobing, Daniel
    Wouters, Noemi
    van der Vijver, Rozemarijn
    Lo, Queenie
    Rajaratnam, Rohan
    Hopkins, Andrew P.
    Lo, Sidney
    Leung, Dominic
    Juergens, Craig P.
    French, John K.
    AMERICAN HEART JOURNAL, 2012, 163 (04) : 649 - +
  • [7] Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction
    Eisenberg, MJ
    Jamal, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 1 - 6
  • [8] Feasibility and Safety of Prehospital Administration of Bivalirudin in Patients With ST-Elevation Myocardial Infarction
    Sejersten, Maria
    Nielsen, Soren Loumann
    Engstrom, Thomas
    Jorgensen, Erik
    Clemmensen, Peter
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (12): : 1635 - 1640
  • [9] Is Still There a Place for Glycoprotein IIb-IIIa Inhibitors in Modern Treatment of ST-Elevation Myocardial Infarction?
    Jorge, Elisabete
    Baptista, Rui
    Teixeira, Rogerio
    Saraiva, Fatima
    Mendes, Paulo
    Lourenco, Carolina
    Goncalves, Francisco
    Monteiro, Pedro
    Freitas, Mario
    Providencia, La
    CIRCULATION, 2010, 122 (02) : E249 - E249
  • [10] Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction
    Holper, EM
    Giugliano, RP
    Antman, EM
    CORONARY ARTERY DISEASE, 1999, 10 (08) : 567 - 573
12345